Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.

Cell Rep Med · 2026 · PMC13400186 · PMID 42276053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differentially expressed genes (DEGs) with highly significant fold changes were identified, and the top 50 DEGs in TMZ-resistant and TMZ-sensitive GBOs were visualized ( Figure 4 A).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.